The largest exchange-traded fund to track the biotechnology sector rallied on Monday, supported by a pair of multibillion-dollar deals. The iShares Nasdaq Biotechnology ETF jumped 1.8%. At current levels, the fund is trading at its highest level since October. However, if it ends the day at its current price, that would represent its highest close since December 2015. The ETF is up 6.8% thus far this year, above the 5.1% advance of the S&P 500 . In the day’s deal news, Juno Therapeutics Inc. jumped 27% after Celgene Corp. agreed to buy the company for $9 billion. Bioverativ Inc. soared 63% after Sanofi SA said it would buy it for $12 billion.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News